| Schedule of calculation of basic and diluted net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
|
|
December 31,
|
|
December 31,
|
|
|
|
2019
|
|
2018
|
|
2019
|
|
2018
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders
|
|
$
|
(16,189)
|
|
$
|
(7,673)
|
|
$
|
(36,836)
|
|
$
|
(24,178)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding, basic and diluted
|
|
|
34,877,944
|
|
|
31,577,313
|
|
|
32,742,148
|
|
|
20,433,580
|
|
Net loss per share attributable to common stockholders, basic and diluted
|
|
$
|
(0.46)
|
|
$
|
(0.24)
|
|
$
|
(1.13)
|
|
$
|
(1.18)
|
|
| Schedule of anti-dilutive securities excluded from the computation of diluted net loss per share attributable to common shareholders |
|
|
|
|
|
|
|
|
|
Three and Nine Months Ended
|
|
|
|
December 31,
|
|
|
|
2019
|
|
2018
|
|
Options to purchase common stock
|
|
4,916,402
|
|
3,673,535
|
|
Warrants to purchase convertible preferred stock (as converted to common stock)
|
|
497,344
|
|
497,344
|
|
|
|
5,413,746
|
|
4,170,879
|
|